Header Logo

Connection

DOV KADMON to Transduction, Genetic

Back to Details
This is a "connection" page, showing publications DOV KADMON has written about Transduction, Genetic.
DOV KADMON
Connection Strength
0.016
Transduction, Genetic
  1. IL-12 gene-modified bone marrow cell therapy suppresses the development of experimental metastatic prostate cancer. Cancer Gene Ther. 2007 Oct; 14(10):819-27.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.